iShares Biotechnology ETF

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete…
Read More...

Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's…
Read More...

Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to…
Read More...

The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli…
Read More...

Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest…
Read More...

Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for…
Read More...

GlaxoSmithKline headquarters in London on Jan. 17, 2022.Hannah Mckay | ReutersU.K. pharmaceutical group GSK has…
Read More...

Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the…
Read More...

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to…
Read More...

One of America's largest pharmaceutical companies this week said it will partner with a Chinese drugmaker to test…
Read More...